Valeriia A. Amanatova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Valeriia A. Amanatova has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana M. Uskach
FSBI «NMRC of cardiology named after academician E.I.Chazov» of the MH RF
28 shared publications - Oleg V. Sapelnikov
FSBI «NMRC of cardiology named after academician E.I.Chazov» of the MH RF
19 shared publications - Sergey Tereshchenko
Chazov National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education
17 shared publications - Igor R. Grishin
FSBI «NMRC of cardiology named after academician E.I.Chazov» of the MH RF
12 shared publications - Aleksei A. Ansheles
Department of Myocardial Diseases and Heart Failure, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia
10 shared publications - Anna V. Vereshchagina
FSBI «NMRC of cardiology named after academician E.I.Chazov» of the MH RF
10 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 98-106
Analysis of complications of transvenous extraction of electrodes of cardiac implantable devices
Introduction. The widespread use of cardiac implantable electronic devices (CIEDs) has led to a natural increase in the number of patients requiring transvenous lead extraction (TLE) due to infectious complications and system dysfunction. Despite refined techniques, TLE remains a procedure with a risk of life-threatening complications, such as cardiac perforation or major vein rupture, with an associated mortality rate of up to 50%. Several predictive risk scores (MB Score, LED Score, SAFeTY Score, EROS) have been proposed for risk stratification; however, there is no unified consensus regarding their applicability, diagnostic value, or the most significant predictors. Objective. To conduct a comparative analysis of the prognostic value of existing risk scores (MB Score, LED Score, SAFeTY Score, EROS) and to identify independent predictors of major intraoperative complications during transvenous lead extraction (TLE). Materials and Methods. A multicenter retrospective study included 300 patients who underwent TLE between 2019 and 2023. All patients underwent preoperative risk stratification using four prognostic risk scores. Statistical analysis included correlation analysis (Spearman's coefficient) and ROC analysis. To assess the independent effect of predictors on the development of major complications, binary logistic regression with forward stepwise selection was used. Results. Major complications were recorded in 11 (3.7%) patients. A statistically significant positive correlation was found between the development of complications and scores on the MB Score (r=0.156; p=0.007), LED Score (r=0.155; p=0.007), and SAFeTY Score (r=0.13; p=0.024), and EROS Score (r=0.134; p=0.021). ROC analysis demonstrated that the MB Score (AUC 0.737; p=0.008) and LED Score (AUC 0.739; p=0.007) had the best diagnostic performance; SAFeTY Score showed moderate predictive quality (AUC 0.699; p=0.025), while EROS Score showed borderline statistical significance (AUC 0.673; p=0.051). ROC analysis identified additional factors associated with complications: lead age > 126 months, infection duration > 4.5 months, eGFR < 73 mL/min, female sex, diabetes mellitus, passive lead fixation, and the presence of cut or fractured leads. In stepwise logistic regression of the four risk scores, only LED Score was included in the final model (OR=1.087; 95% CI: 1.019–1.159; p=0.011). When the additional factors were tested in the multivariate model, only infection duration > 4.5 months retained independent significance (OR=4.114; 95% CI: 1.120–15.109; p=0.033). Female sex showed a trend toward significance (p=0.056). The remaining factors lost their prognostic significance after adjustment. Conclusion: TLE is a safe and effective method with a major complication rate of 3.7%. LED Score is the most informative prognostic scale, and infection duration > 4.5 months is an additional independent predictor of complications, supporting the need for timely referral of patients for surgical treatment. Consideration of these factors improves perioperative risk stratification and optimizes the choice of surgical strategy.
- 30 September 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 98-106
Open AccessAnalysis of complications of transvenous extraction of electrodes of cardiac implantable devices
Introduction. The widespread use of cardiac implantable electronic devices (CIEDs) has led to a natural increase in the number of patients requiring transvenous lead extraction (TLE) due to infectious complications and system dysfunction. Despite refined techniques, TLE remains a procedure with a risk of life-threatening complications, such as cardiac perforation or major vein rupture, with an associated mortality rate of up to 50%. Several predictive risk scores (MB Score, LED Score, SAFeTY Score, EROS) have been proposed for risk stratification; however, there is no unified consensus regarding their applicability, diagnostic value, or the most significant predictors. Objective. To conduct a comparative analysis of the prognostic value of existing risk scores (MB Score, LED Score, SAFeTY Score, EROS) and to identify independent predictors of major intraoperative complications during transvenous lead extraction (TLE). Materials and Methods. A multicenter retrospective study included 300 patients who underwent TLE between 2019 and 2023. All patients underwent preoperative risk stratification using four prognostic risk scores. Statistical analysis included correlation analysis (Spearman's coefficient) and ROC analysis. To assess the independent effect of predictors on the development of major complications, binary logistic regression with forward stepwise selection was used. Results. Major complications were recorded in 11 (3.7%) patients. A statistically significant positive correlation was found between the development of complications and scores on the MB Score (r=0.156; p=0.007), LED Score (r=0.155; p=0.007), and SAFeTY Score (r=0.13; p=0.024), and EROS Score (r=0.134; p=0.021). ROC analysis demonstrated that the MB Score (AUC 0.737; p=0.008) and LED Score (AUC 0.739; p=0.007) had the best diagnostic performance; SAFeTY Score showed moderate predictive quality (AUC 0.699; p=0.025), while EROS Score showed borderline statistical significance (AUC 0.673; p=0.051). ROC analysis identified additional factors associated with complications: lead age > 126 months, infection duration > 4.5 months, eGFR < 73 mL/min, female sex, diabetes mellitus, passive lead fixation, and the presence of cut or fractured leads. In stepwise logistic regression of the four risk scores, only LED Score was included in the final model (OR=1.087; 95% CI: 1.019–1.159; p=0.011). When the additional factors were tested in the multivariate model, only infection duration > 4.5 months retained independent significance (OR=4.114; 95% CI: 1.120–15.109; p=0.033). Female sex showed a trend toward significance (p=0.056). The remaining factors lost their prognostic significance after adjustment. Conclusion: TLE is a safe and effective method with a major complication rate of 3.7%. LED Score is the most informative prognostic scale, and infection duration > 4.5 months is an additional independent predictor of complications, supporting the need for timely referral of patients for surgical treatment. Consideration of these factors improves perioperative risk stratification and optimizes the choice of surgical strategy.
- Open Access
- 23 September 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (3) , 13-18
A new method of transseptal puncture without fluoroscopy and ultrasound imaging - «double zero»
Electroanatomic mapping is an effective imaging tool for the catheter treatment of various arrhythmias. Nevertheless, to perform puncture of interatrial septum, it is common to use an additional imaging tool - fluoroscopy or echocardiography. There is only limited data about the possibility of performing a transseptal puncture under the control of exclusively electroanatomic mapping. The method described by us is based on the use of an visualized intracardiac navigation introducer and a circular multipolar diagnostic catheter acting as a guidewire during catheterization of the left atrium.
- 23 September 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (3) , 13-18
Open AccessA new method of transseptal puncture without fluoroscopy and ultrasound imaging - «double zero»
Electroanatomic mapping is an effective imaging tool for the catheter treatment of various arrhythmias. Nevertheless, to perform puncture of interatrial septum, it is common to use an additional imaging tool - fluoroscopy or echocardiography. There is only limited data about the possibility of performing a transseptal puncture under the control of exclusively electroanatomic mapping. The method described by us is based on the use of an visualized intracardiac navigation introducer and a circular multipolar diagnostic catheter acting as a guidewire during catheterization of the left atrium.
- Open Access
- 28 August 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (8) , 4800
Evaluation of multisensor data for diagnosing clinical deterioration in patients with heart failure and implantable cardioverter-defibrillators
Aim . To evaluate the potential of multisensor monitoring by an implantable cardioverter-defibrillator (ICD) for detecting clinical deterioration of heart failure (HF) by comparing sensor data with laboratory, functional, and clinical parameters. Material and methods . This prospective study included 56 patients with NYHA class II-III HF and a left ventricular ejection fraction ≤35% who were implanted with multisensor ICDs. Follow-up visits were conducted at 6 and 12 months, including the 6-minute walk test (6MWT), echocardiography, N-terminal pro-brain natriuretic peptide (NT-proBNP) level assessment, and device interrogation with sensor data analysis. Based on the 6-month visit results, patients were divided into groups with and without clinical HF deterioration. Deterioration criteria included at least one of the following: a decrease in 6MWT distance, edema worsening, or an increase in NT-proBNP levels by >30% from baseline, combined with a HeartLogic index exceeding the threshold >16. Correlation analysis was used to assess associations between selected multisensor monitoring parameters and clinical/laboratory indicators in the entire cohort. Additionally, an exploratory subgroup analysis was performed for patients with clinical HF deterioration. Results . Heart failure (HF) clinical worsening after 6 months was observed in 22 (39,3%) patients and was associated with unfavorable changes of multisensor parameters compared to patients without HF progression, an increase in NT-proBNP levels (2182 vs 847 pg/mL; pConclusion . Multisensor ICD monitoring is associated with clinical, laboratory, and functional signs of HF worsening. Unfavorable dynamics of individual device-detected parameters were accompanied by higher NT-proBNP levels, reduced 6MWT distance, and less favorable echocardiographic indices, which confirms the potential of multisensor monitoring for proactive and personalized patient management and warrants further investigation in larger prospective studies.
- 28 August 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (8) , 4800
Open AccessEvaluation of multisensor data for diagnosing clinical deterioration in patients with heart failure and implantable cardioverter-defibrillators
Aim . To evaluate the potential of multisensor monitoring by an implantable cardioverter-defibrillator (ICD) for detecting clinical deterioration of heart failure (HF) by comparing sensor data with laboratory, functional, and clinical parameters. Material and methods . This prospective study included 56 patients with NYHA class II-III HF and a left ventricular ejection fraction ≤35% who were implanted with multisensor ICDs. Follow-up visits were conducted at 6 and 12 months, including the 6-minute walk test (6MWT), echocardiography, N-terminal pro-brain natriuretic peptide (NT-proBNP) level assessment, and device interrogation with sensor data analysis. Based on the 6-month visit results, patients were divided into groups with and without clinical HF deterioration. Deterioration criteria included at least one of the following: a decrease in 6MWT distance, edema worsening, or an increase in NT-proBNP levels by >30% from baseline, combined with a HeartLogic index exceeding the threshold >16. Correlation analysis was used to assess associations between selected multisensor monitoring parameters and clinical/laboratory indicators in the entire cohort. Additionally, an exploratory subgroup analysis was performed for patients with clinical HF deterioration. Results . Heart failure (HF) clinical worsening after 6 months was observed in 22 (39,3%) patients and was associated with unfavorable changes of multisensor parameters compared to patients without HF progression, an increase in NT-proBNP levels (2182 vs 847 pg/mL; pConclusion . Multisensor ICD monitoring is associated with clinical, laboratory, and functional signs of HF worsening. Unfavorable dynamics of individual device-detected parameters were accompanied by higher NT-proBNP levels, reduced 6MWT distance, and less favorable echocardiographic indices, which confirms the potential of multisensor monitoring for proactive and personalized patient management and warrants further investigation in larger prospective studies.
- Open Access
- 27 July 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (6) , 373-378
Chronic heart failure with improved ejection fraction. A review of the problem
Chronic heart failure is a leading cause of increased mortality rates globally, including in the Russian Federation. Guideline-directed medical therapy plays a key role in the management of this patient cohort, particularly among individuals with reduced left ventricular ejection fraction. Of special interest is the subgroup with improved left ventricular ejection fraction, for which data remain limited and the issue of further medical treatment remains unresolved. This review aims to categorize this patient population and address the feasibility of discontinuing or reducing medical therapy.
- 27 July 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (6) , 373-378
Open AccessChronic heart failure with improved ejection fraction. A review of the problem
Chronic heart failure is a leading cause of increased mortality rates globally, including in the Russian Federation. Guideline-directed medical therapy plays a key role in the management of this patient cohort, particularly among individuals with reduced left ventricular ejection fraction. Of special interest is the subgroup with improved left ventricular ejection fraction, for which data remain limited and the issue of further medical treatment remains unresolved. This review aims to categorize this patient population and address the feasibility of discontinuing or reducing medical therapy.
- Open Access
- 13 June 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (2) , 58-64
Reduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming
Aim . Evaluation of a patient group with a reduced percentage of stimulation, pain sensation, and the impact of adjusting stimulation programming parameters on achieving a positive effect from cardiac contractility modulation (CCM) therapy. Methods . The study included 117 patients implanted with a CCM device. Personalized parameter settings were programmed intraoperatively and postoperatively. Transthoracic echocardiography (TTE) was performed before implantation and 6 months after surgery. Results . The median age was 59.5 years, with 93.7% being male patients. The primary etiology of heart failure was ischemic heart disease (53.8%). A part of patients required a reduction in stimulation amplitude from 7.5 V (79%) to a maximum of 5 V (9%). After 6 months, the group with 7.5 V stimulation amplitude showed a significant increase in LVEF to 37 [32; 43] % (p=0.0001). However, in the group with 5 V stimulation amplitude, the increase in LVEF did not reach statistical significance during follow-up: 35 [34; 40] (p=0.211). Patients without discomfort during CCM therapy had lower LVEF (p=0.048), increased LV volumes (p=0.024; p=0.034), and a thinner LV posterior wall (p=0.028). However, the relationship between cardiac wall thickness and pain during ССМ therapy requires further research. Also, in patients without stimulation discomfort, the electrodes were more frequently implanted in the middle third of the interventricular septum (p=0.025). 83.7% of patients were programmed with standard stimulation duration - 7 hours per day (hrs/day). For 5.9%, the stimulation duration was 10 to 14 hours due to failure to achieve the required stimulation percentage. In this patient group, increasing the stimulation duration achieved a stimulation percentage exceeding 70%. In 15.3% of cases, patients with a CCM device had a therapy percentage above 90%. In 68.3% of cases, the daily therapy percentage was 80- 90%, and in 12% - 70 to 80%. A positive, moderate, significant correlation was noted between the stimulation percentage and the increase in LVEF (r=0.3; p=0.05). Conclusion . CCM is an effective method of interventional treatment for patients with CHF. When programming CCM devices, it is necessary to achieve a stimulation percentage exceeding 70% per day, as the stimulation percentage directly correlates with an increase in myocardial contractility. Additionally, the stimulation amplitude should reach the target level of 7.5 V. If pain occurs, a reduction in stimulation amplitude to the minimum tolerable level is permissible. Further study of the nuances of device operation and training of specialists in programming intracardiac devices are necessary.
- 13 June 2026
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 33 (2) , 58-64
Open AccessReduction in pacing rate and pain during cardiac contractility modulation: an overview of the problem and its solution using device programming
Aim . Evaluation of a patient group with a reduced percentage of stimulation, pain sensation, and the impact of adjusting stimulation programming parameters on achieving a positive effect from cardiac contractility modulation (CCM) therapy. Methods . The study included 117 patients implanted with a CCM device. Personalized parameter settings were programmed intraoperatively and postoperatively. Transthoracic echocardiography (TTE) was performed before implantation and 6 months after surgery. Results . The median age was 59.5 years, with 93.7% being male patients. The primary etiology of heart failure was ischemic heart disease (53.8%). A part of patients required a reduction in stimulation amplitude from 7.5 V (79%) to a maximum of 5 V (9%). After 6 months, the group with 7.5 V stimulation amplitude showed a significant increase in LVEF to 37 [32; 43] % (p=0.0001). However, in the group with 5 V stimulation amplitude, the increase in LVEF did not reach statistical significance during follow-up: 35 [34; 40] (p=0.211). Patients without discomfort during CCM therapy had lower LVEF (p=0.048), increased LV volumes (p=0.024; p=0.034), and a thinner LV posterior wall (p=0.028). However, the relationship between cardiac wall thickness and pain during ССМ therapy requires further research. Also, in patients without stimulation discomfort, the electrodes were more frequently implanted in the middle third of the interventricular septum (p=0.025). 83.7% of patients were programmed with standard stimulation duration - 7 hours per day (hrs/day). For 5.9%, the stimulation duration was 10 to 14 hours due to failure to achieve the required stimulation percentage. In this patient group, increasing the stimulation duration achieved a stimulation percentage exceeding 70%. In 15.3% of cases, patients with a CCM device had a therapy percentage above 90%. In 68.3% of cases, the daily therapy percentage was 80- 90%, and in 12% - 70 to 80%. A positive, moderate, significant correlation was noted between the stimulation percentage and the increase in LVEF (r=0.3; p=0.05). Conclusion . CCM is an effective method of interventional treatment for patients with CHF. When programming CCM devices, it is necessary to achieve a stimulation percentage exceeding 70% per day, as the stimulation percentage directly correlates with an increase in myocardial contractility. Additionally, the stimulation amplitude should reach the target level of 7.5 V. If pain occurs, a reduction in stimulation amplitude to the minimum tolerable level is permissible. Further study of the nuances of device operation and training of specialists in programming intracardiac devices are necessary.
- 28 May 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 2
The effect of correction of HF therapy based on indicators of multisensory ICD sensors on the clinical course of the disease and the frequency of shocks
Objective: to evaluate the effect of correction of HF therapy based on indicators of multisensory ICD sensors on the clinical course of the disease and the frequency of shocks. Materials and methods. 111 patients with HF and indications for ICD implantation for the primary prevention of sudden cardiac death were included in the prospective study, then they were divided into two groups: in the studied (n=56) ICD with a multisensory set of sensors; in the comparison group (n=55), standard ICD without sensors. The patients were monitored for 12 months, and the dynamics of quality of life, clinical and laboratory parameters, device monitoring data, discharge episodes, and the number of hospitalizations due to HF decompensation were analyzed. Results. The patient groups were initially comparable in terms of gender, age, etiology of the disease and severity of the condition. All patients were on optimal medication therapy for HF for more than 3 months. Initially, there were no significant differences in the level of NTpro-BNP and the six-minute walking test distance, and there were no еchocardiography indices in both groups. After 6 months, during device interrogation, diuretic therapy was changed in the study group, taking into account the indicators of multisensory sensors, in the comparison group only based on clinical data. After 12 months, both groups showed positive dynamics in the quality of life index; a significant increase in ejection fraction and NT-proBNP levels in the study group, a significant decrease in the six-minute walking test distance in the comparison group, a comparable number of both adequate and inadequate ICD discharges, and a significantly lower number of hospitalizations for decompensation in the study group. Conclusion. The use of ICD multisensory monitoring was associated with a statistically significant improvement in the clinical course of HF and the frequency of shocks in patients compared with standard ICD.
- 28 May 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 2
The effect of correction of HF therapy based on indicators of multisensory ICD sensors on the clinical course of the disease and the frequency of shocks
Objective: to evaluate the effect of correction of HF therapy based on indicators of multisensory ICD sensors on the clinical course of the disease and the frequency of shocks. Materials and methods. 111 patients with HF and indications for ICD implantation for the primary prevention of sudden cardiac death were included in the prospective study, then they were divided into two groups: in the studied (n=56) ICD with a multisensory set of sensors; in the comparison group (n=55), standard ICD without sensors. The patients were monitored for 12 months, and the dynamics of quality of life, clinical and laboratory parameters, device monitoring data, discharge episodes, and the number of hospitalizations due to HF decompensation were analyzed. Results. The patient groups were initially comparable in terms of gender, age, etiology of the disease and severity of the condition. All patients were on optimal medication therapy for HF for more than 3 months. Initially, there were no significant differences in the level of NTpro-BNP and the six-minute walking test distance, and there were no еchocardiography indices in both groups. After 6 months, during device interrogation, diuretic therapy was changed in the study group, taking into account the indicators of multisensory sensors, in the comparison group only based on clinical data. After 12 months, both groups showed positive dynamics in the quality of life index; a significant increase in ejection fraction and NT-proBNP levels in the study group, a significant decrease in the six-minute walking test distance in the comparison group, a comparable number of both adequate and inadequate ICD discharges, and a significantly lower number of hospitalizations for decompensation in the study group. Conclusion. The use of ICD multisensory monitoring was associated with a statistically significant improvement in the clinical course of HF and the frequency of shocks in patients compared with standard ICD.
- 25 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 48-55
Monitoring of chronic heart failure using transthoracic impedance and heart rate variability sensor in patients with cardioverter defibrillator
Objective. To evaluate the role of transthoracic impedance (TTI) and heart rate variability (HRV) in control of HF deterioration in patients with implanted ICD. Material and methods. The study included 48 patients with HF class II-III, LVEF<35% and indications for primary prevention of SCD. They received optimal therapy of HF for more than three months. The patients were implanted with CHARISMA TM EL ICD Boston Scientific, and then they were followed-up for 6 months. We evaluated the indicators of TTI and HRV sensors during ICD intervention, the number of shocks, clinical and laboratory dynamics of HF and quality of life, as well as the need for diuretic therapy. Results. Mean age of patients was 56.4±13.6 years, male patients predominated. Coronary artery disease, dilated cardiomyopathy and hypertension were the main causes of HF. We identified patients (n=17) with clinical deterioration of HF defined as the presence of at least one of the following signs: increased HF class, decreased 6MWT distance and higher need for diuretic therapy. At ICD interrogation, this group demonstrated lower TTI and HRV values, higher NT-proBNP and decreased 6MWT distance. Conclusion. TTI and HRV in patients with CVD can serve as an accurate indicator for predicting and detecting deterioration of CHF.
- 25 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 48-55
Monitoring of chronic heart failure using transthoracic impedance and heart rate variability sensor in patients with cardioverter defibrillator
Objective. To evaluate the role of transthoracic impedance (TTI) and heart rate variability (HRV) in control of HF deterioration in patients with implanted ICD. Material and methods. The study included 48 patients with HF class II-III, LVEF<35% and indications for primary prevention of SCD. They received optimal therapy of HF for more than three months. The patients were implanted with CHARISMA TM EL ICD Boston Scientific, and then they were followed-up for 6 months. We evaluated the indicators of TTI and HRV sensors during ICD intervention, the number of shocks, clinical and laboratory dynamics of HF and quality of life, as well as the need for diuretic therapy. Results. Mean age of patients was 56.4±13.6 years, male patients predominated. Coronary artery disease, dilated cardiomyopathy and hypertension were the main causes of HF. We identified patients (n=17) with clinical deterioration of HF defined as the presence of at least one of the following signs: increased HF class, decreased 6MWT distance and higher need for diuretic therapy. At ICD interrogation, this group demonstrated lower TTI and HRV values, higher NT-proBNP and decreased 6MWT distance. Conclusion. TTI and HRV in patients with CVD can serve as an accurate indicator for predicting and detecting deterioration of CHF.
- Open Access
- 20 October 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (9) , 762-772
Cardiology and cardiac surgery – a symbiosis of successful treatment of heart failure
Currently, the proportion of patients with heart failure is progressively increasing. Despite the progress in drug therapy, additional manipulations are often necessary to correct cardiovascular pathology in these patients. Given the high comorbidity, the use of classical surgical techniques is impossible in some cases. Implantation of high-tech devices, catheter ablation of arrhythmogenic areas, transcatheter mitral valve plastic surgery are minimally invasive surgical methods. Proper interaction between a cardiologist and a cardiovascular surgeon allows for the maximum personalization of the approach to the treatment of each patient, achieving maximum results with significantly reduced risks.
- 20 October 2025
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (9) , 762-772
Open AccessCardiology and cardiac surgery – a symbiosis of successful treatment of heart failure
Currently, the proportion of patients with heart failure is progressively increasing. Despite the progress in drug therapy, additional manipulations are often necessary to correct cardiovascular pathology in these patients. Given the high comorbidity, the use of classical surgical techniques is impossible in some cases. Implantation of high-tech devices, catheter ablation of arrhythmogenic areas, transcatheter mitral valve plastic surgery are minimally invasive surgical methods. Proper interaction between a cardiologist and a cardiovascular surgeon allows for the maximum personalization of the approach to the treatment of each patient, achieving maximum results with significantly reduced risks.
- Open Access
- 5 September 2025
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 32 (3) , 29-36
Evaluation of the ablation index during catheter treatment without fluoroscopy in patients with coronary heart disease and systolic dysfunction
Aim. To study the ablation index (AI) in the context of catheter treatment of ventricular tachycardia (VT) without the use of fluoroscopy in patients with chronic heart failure.Methods. Catheter ablation of VT was performed in 47 patients with coronary heart disease and chronic heart failure. Intraoperative parameters of the ablation, including the average ablation index, were assessed. The fact of arrhythmia induction after a series of radiofrequency exposures was assessed. Recurrence of VT was also assessed. The observation period was 12 months.Results. During surgery after ablation exposure, arrhythmia induction was impossible in 100% of patients. After 12 months of observation, freedom from arrhythmia was 84,8%. Patients without recurrence of VT had a statistically significantly higher mean AI (612 [522,5; 683,5]) than with recurrence of VT (7 (15,2%) patients) (438 [416,5; 462]) (p=0,001). The possibility of predicting recurrence of VT depending on the mean AI value was also assessed. It was found that with the mean AI value greater than or equal to 473, the risk of recurrence of VT is lower (p=0,001).Conclusions. AI can be used as a parameter for monitoring effective ablation exposure in the context of catheter ablation of VT along with other determinants currently used.
- 5 September 2025
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 32 (3) , 29-36
Open AccessEvaluation of the ablation index during catheter treatment without fluoroscopy in patients with coronary heart disease and systolic dysfunction
Aim. To study the ablation index (AI) in the context of catheter treatment of ventricular tachycardia (VT) without the use of fluoroscopy in patients with chronic heart failure.Methods. Catheter ablation of VT was performed in 47 patients with coronary heart disease and chronic heart failure. Intraoperative parameters of the ablation, including the average ablation index, were assessed. The fact of arrhythmia induction after a series of radiofrequency exposures was assessed. Recurrence of VT was also assessed. The observation period was 12 months.Results. During surgery after ablation exposure, arrhythmia induction was impossible in 100% of patients. After 12 months of observation, freedom from arrhythmia was 84,8%. Patients without recurrence of VT had a statistically significantly higher mean AI (612 [522,5; 683,5]) than with recurrence of VT (7 (15,2%) patients) (438 [416,5; 462]) (p=0,001). The possibility of predicting recurrence of VT depending on the mean AI value was also assessed. It was found that with the mean AI value greater than or equal to 473, the risk of recurrence of VT is lower (p=0,001).Conclusions. AI can be used as a parameter for monitoring effective ablation exposure in the context of catheter ablation of VT along with other determinants currently used.
- Open Access
- 20 April 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (3) , 4191
Cardiac contractility modulation in patients with heart failure with reduced ejection fraction: a meta-analysis of Russian clinical trials
Aim. To perform a meta-analysis of Russian clinical trials and study the associations of cardiac contractility modulation in patients with heart failure with reduced left ventricular ejection fraction (LVEF).Material and methods. In the meta-analysis; the following outcome measures were selected: Minnesota Living With Heart Failure Questionnaire (MLWHFQ); 6-minute walk test (6MWT); improvement in heart failure functional class; echocardiography data: LVEF; LV end-systolic and end-diastolic volumes; as well as survival rates at 12 and 24 months.Results. The results included in the meta-analysis showed a significant improvement in the 6MWT distance (n=216) (mean difference -38;19; 95% confidence interval (CI): -65;46 to -10;91 m; p=0;006); MLWHFQ results (mean difference 7;28; 95% CI: 2;87-11;69; p=0;001); LVEF (mean difference -4;02; 95% CI: from -5;83 to 2;20; pConclusion. The results of the data from 3 Russian clinical non-randomized studies included in the meta-analysis suggest that cardiac contractility modulation is associated with a significant improvement in quality of life; 6MWT distance; and reverse LV myocardial remodeling.
- 20 April 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (3) , 4191
Open AccessCardiac contractility modulation in patients with heart failure with reduced ejection fraction: a meta-analysis of Russian clinical trials
Aim. To perform a meta-analysis of Russian clinical trials and study the associations of cardiac contractility modulation in patients with heart failure with reduced left ventricular ejection fraction (LVEF).Material and methods. In the meta-analysis; the following outcome measures were selected: Minnesota Living With Heart Failure Questionnaire (MLWHFQ); 6-minute walk test (6MWT); improvement in heart failure functional class; echocardiography data: LVEF; LV end-systolic and end-diastolic volumes; as well as survival rates at 12 and 24 months.Results. The results included in the meta-analysis showed a significant improvement in the 6MWT distance (n=216) (mean difference -38;19; 95% confidence interval (CI): -65;46 to -10;91 m; p=0;006); MLWHFQ results (mean difference 7;28; 95% CI: 2;87-11;69; p=0;001); LVEF (mean difference -4;02; 95% CI: from -5;83 to 2;20; pConclusion. The results of the data from 3 Russian clinical non-randomized studies included in the meta-analysis suggest that cardiac contractility modulation is associated with a significant improvement in quality of life; 6MWT distance; and reverse LV myocardial remodeling.